Thinking of joining a study?

Register your interest

NCT04670874 | RECRUITING | Cutaneous Lymphoma


Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
Sponsor:

City of Hope Medical Center

Brief Summary:

This study assesses the quality of life in patients with cutaneous lymphoma diagnosis as it relates to their personal, clinical, and therapeutic information using the Skindex29 questionnaire and also assesses patients' understanding of their diagnosis and need for resources related to their care. Cutaneous lymphomas are a rare type of blood cancers (non-Hodgkin lymphoma) that present in the skin. The information gained from this study, may help researchers improve quality of life in cutaneous lymphoma patients.

Condition or disease

Cutaneous Lymphoma

Intervention/treatment

Quality-of-Life Assessment

Questionnaire Administration

Detailed Description:

PRIMARY OBJECTIVES: I. To prospectively assess quality of life (QoL) in adult patients with cutaneous lymphoma (CL) via use of a validated questionnaire (Skindex-29) and identify the psychosocial needs of our patient population. II. To prospectively evaluate the burden of pruritus in patients with CL via use of 10-point pruritus scale and compare to QoL. III. To evaluate QoL for any correlation with demographic and clinical information, specifically, age, gender, race/ethnicity, type of CL, stage of mycosis fungoides (MF)/Sezary syndrome (SS), treatment regimen, and social work involvement. IV. To track changes in QoL and burden of pruritus as they relate to therapeutic strategies used to manage disease, including social work involvement. V. To prospectively assess patients' knowledge and understanding of their cancer diagnosis, prognosis, and overall survival; and to track changes in their knowledge and understanding, and assess for any correlation to QoL. VI. To prospectively evaluate our patients' need for resources, and our ability to meet those needs; and to assess for any correlation to demographic or clinical category, or QoL. OUTLINE: Patients complete quality of life questionnaires over 10-20 minutes about symptoms, emotions, and functioning related to diagnosis of cutaneous lymphoma.

Study Type : OBSERVATIONAL
Estimated Enrollment : 1250 participants
Official Title : Assessment of Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
Actual Study Start Date : 2023-08-17
Estimated Primary Completion Date : 2034-01-24
Estimated Study Completion Date : 2034-01-24

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Agreement to participate in the research study
  • * Presumed or confirmed diagnosis of CL

Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29

Location Details

NCT04670874


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, California

City of Hope Medical Center

Duarte, California, United States, 91010

Loading...